Home/Filings/4/0001062993-24-004312
4//SEC Filing

Freedman Lori 4

Accession 0001062993-24-004312

CIK 0001661181other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:23 PM ET

Size

7.2 KB

Accession

0001062993-24-004312

Insider Transaction Report

Form 4
Period: 2024-02-21
Freedman Lori
Chief Admin. and Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-21+276,737276,737 total
    Exercise: $3.43Exp: 2034-02-21Class A Common Stock (276,737 underlying)
  • Award

    Class A Common Stock

    2024-02-21+153,061471,246 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2024.
  • [F2]The option becomes exercisable in equal annual installments over four years beginning February 15, 2024.

Issuer

Organogenesis Holdings Inc.

CIK 0001661181

Entity typeother

Related Parties

1
  • filerCIK 0001410291

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:23 PM ET
Size
7.2 KB